Vojtech Melenovsky1, Katerina Hlavata1, Petr Sedivy2, Monika Dezortova2, Barry A Borlaug3, Jiri Petrak1, Josef Kautzner4, Milan Hajek2. 1. Department of Cardiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (V.M., K.H., J.K.). 2. Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (P.S., M.D., M.H.). 3. Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN (B.A.B.). 4. BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic (J.P.).
Abstract
BACKGROUND: Heart failure (HF) is often associated with iron deficiency (ID). Skeletal muscle abnormalities are common in HF, but the potential role of ID in this phenomenon is unclear. In addition to hemopoiesis, iron is essential for muscle bioenergetics. We examined whether energetic abnormalities in skeletal muscle in HF are affected by ID and if they are responsive to intravenous iron. METHODS AND RESULTS: Forty-four chronic HF subjects and 25 similar healthy volunteers underwent 31P magnetic resonance spectroscopy of calf muscle at rest and during exercise (plantar flexions). Results were compared between HF subjects with or without ID. In 13 ID-HF subjects, examinations were repeated 1 month after intravenous ferric carboxymaltose administration (1000 mg). As compared with controls, HF subjects displayed lower resting high-energy phosphate content, lower exercise pH, and slower postexercise PCr recovery. Compared with non-ID HF, ID-HF subjects had lower muscle strength, larger PCr depletion, and more profound intracellular acidosis with exercise, consistent with an earlier metabolic shift to anaerobic glycolysis. The exercise-induced PCr drop strongly correlated with pH change in HF group ( r=-0.71, P<0.001) but not in controls ( r=0.13, P=0.61, interaction: P<0.0001). Short-term iron administration corrected the iron deficit but had no effect on muscle bioenergetics assessed 1 month later. CONCLUSIONS: HF patients display skeletal muscle myopathy that is more severe in those with iron deficiency. The presence of ID is associated with greater acidosis with exercise, which may explain early muscle fatigue. Further study is warranted to identify the strategy to restore iron content in skeletal muscle.
BACKGROUND:Heart failure (HF) is often associated with iron deficiency (ID). Skeletal muscle abnormalities are common in HF, but the potential role of ID in this phenomenon is unclear. In addition to hemopoiesis, iron is essential for muscle bioenergetics. We examined whether energetic abnormalities in skeletal muscle in HF are affected by ID and if they are responsive to intravenous iron. METHODS AND RESULTS: Forty-four chronic HF subjects and 25 similar healthy volunteers underwent 31P magnetic resonance spectroscopy of calf muscle at rest and during exercise (plantar flexions). Results were compared between HF subjects with or without ID. In 13 ID-HF subjects, examinations were repeated 1 month after intravenous ferric carboxymaltose administration (1000 mg). As compared with controls, HF subjects displayed lower resting high-energy phosphate content, lower exercise pH, and slower postexercise PCr recovery. Compared with non-ID HF, ID-HF subjects had lower muscle strength, larger PCr depletion, and more profound intracellular acidosis with exercise, consistent with an earlier metabolic shift to anaerobic glycolysis. The exercise-induced PCr drop strongly correlated with pH change in HF group ( r=-0.71, P<0.001) but not in controls ( r=0.13, P=0.61, interaction: P<0.0001). Short-term iron administration corrected the iron deficit but had no effect on muscle bioenergetics assessed 1 month later. CONCLUSIONS: HF patients display skeletal muscle myopathy that is more severe in those with iron deficiency. The presence of ID is associated with greater acidosis with exercise, which may explain early muscle fatigue. Further study is warranted to identify the strategy to restore iron content in skeletal muscle.
Entities:
Keywords:
heart failure; iron; magnetic resonance spectroscopy; metabolism; muscles
Authors: M Tajes; C Díez-López; C Enjuanes; P Moliner; J L Ferreiro; A Garay; S Jiménez-Marrero; S Yun; S G Sosa; L Alcoberro; J González-Costello; E García-Romero; L Yañez-Bisbe; B Benito; J Comín-Colet Journal: Cell Biosci Date: 2021-05-17 Impact factor: 7.133
Authors: Alexander Dietl; Ingrid Winkel; Gabriela Pietrzyk; Michael Paulus; Astrid Bruckmann; Josef A Schröder; Samuel Sossalla; Andreas Luchner; Lars S Maier; Christoph Birner Journal: PLoS One Date: 2019-12-04 Impact factor: 3.240
Authors: Susanne Macher; Cornelia Herster; Magdalena Holter; Martina Moritz; Eva Maria Matzhold; Tatjana Stojakovic; Thomas R Pieber; Peter Schlenke; Camilla Drexler; Karin Amrein Journal: Nutrients Date: 2020-05-05 Impact factor: 5.717
Authors: Matthew C Frise; David A Holdsworth; Andrew W Johnson; Yu Jin Chung; M Kate Curtis; Pete J Cox; Kieran Clarke; Damian J Tyler; David J Roberts; Peter J Ratcliffe; Keith L Dorrington; Peter A Robbins Journal: Sci Rep Date: 2022-01-19 Impact factor: 4.379